{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:28:42Z","timestamp":1787801322441,"version":"build-2784847793"},"reference-count":38,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.3892\/or.2012.2156","type":"journal-article","created":{"date-parts":[[2012,11,28]],"date-time":"2012-11-28T04:56:45Z","timestamp":1354078605000},"page":"676-684","source":"Crossref","is-referenced-by-count":39,"title":["Mechanisms of verapamil-enhanced chemosensitivity of gallbladder cancer cells to platinum drugs: Glutathione reduction and MRP1 downregulation"],"prefix":"10.3892","volume":"29","author":[{"given":"HAOLU","family":"WANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XINXING","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAO","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WEI","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QIANG","family":"LIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HUI","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JING","family":"YI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIAN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,11,28]]},"reference":[{"key":"key20180107214348_b1-or-29-02-0676","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.amjsurg.2007.11.011","article-title":"Gallbladder cancer","volume":"196","author":"Gourgiotis","year":"2008","journal-title":"Am J Surg"},{"key":"key20180107214348_b2-or-29-02-0676","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1634\/theoncologist.2009-0302","article-title":"Current management of gallbladder carcinoma","volume":"15","author":"Zhu","year":"2010","journal-title":"Oncologist"},{"key":"key20180107214348_b3-or-29-02-0676","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"key20180107214348_b4-or-29-02-0676","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000316848","article-title":"Experience of gemcitabine plus oxaliplatin chemotherapy in patients with advanced biliary tract carcinoma","volume":"56","author":"Hollebecque","year":"2010","journal-title":"Chemotherapy"},{"key":"key20180107214348_b5-or-29-02-0676","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/sj.bjc.6604628","article-title":"Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study","volume":"99","author":"Andre","year":"2008","journal-title":"Br J Cancer"},{"key":"key20180107214348_b6-or-29-02-0676","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/1874467210801020093","article-title":"Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies","volume":"1","author":"Wu","year":"2008","journal-title":"Curr Mol Pharmacol"},{"key":"key20180107214348_b7-or-29-02-0676","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0959-8049(98)00142-7","article-title":"Expression of MDR1 mRNA and encoding P-glycoprotein in archival formalin-fixed paraffin-embedded gall bladder cancer tissues","volume":"34","author":"Cao","year":"1998","journal-title":"Eur J Cancer"},{"key":"key20180107214348_b8-or-29-02-0676","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.bcp.2009.12.006","article-title":"Emodin enhances sensitivity of gallbladder cancer cells to platinum drugs via glutathion depletion and MRP1 downregulation","volume":"79","author":"Wang","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"key20180107214348_b9-or-29-02-0676","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/labinvest.3700127","article-title":"Subcellular localization of the ABCG2 transporter in normal and malignant human gallbladder epithelium","volume":"84","author":"Aust","year":"2004","journal-title":"Lab Invest"},{"key":"key20180107214348_b10-or-29-02-0676","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/1389200013338289","article-title":"The MRP family and anticancer drug metabolism","volume":"2","author":"Suzuki","year":"2001","journal-title":"Curr Drug Metab"},{"key":"key20180107214348_b11-or-29-02-0676","first-page":"871","article-title":"Glutathione-related mechanisms in cellular resistance to anticancer drugs","volume":"12","author":"Zhang","year":"1998","journal-title":"Int J Oncol"},{"key":"key20180107214348_b12-or-29-02-0676","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4161\/cbt.7.3.5457","article-title":"Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells: the mechanisms involve ROS-mediated suppression of multidrug resistance and hypoxia inducible factor-1","volume":"7","author":"Huang","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"key20180107214348_b13-or-29-02-0676","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3727\/096504017X14965095236521","article-title":"Emodin potentiates the anticancer effect of cisplatin on gallbladder cancer cells through the generation of reactive oxygen species and the inhibition of survivin expression","volume":"26","author":"Wang","year":"2011","journal-title":"Oncol Rep"},{"key":"key20180107214348_b14-or-29-02-0676","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.biopha.2010.01.010","article-title":"The mechanisms of somatostatin induced enhanced chemosensitivity of gallbladder cancer cell line to doxorubicin: cell cycle modulation plus target enzyme up-regulation","volume":"64","author":"Quan","year":"2010","journal-title":"Biomed Pharmacother"},{"key":"key20180107214348_b15-or-29-02-0676","first-page":"1501","article-title":"Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo","volume":"40","author":"Zhang","year":"2012","journal-title":"Int J Oncol"},{"key":"key20180107214348_b16-or-29-02-0676","first-page":"231","article-title":"Verapamil enhancement of antitumor effect of cis-diamminedichloroplatinum(II) in nude mouse-grown human neuroblastoma","volume":"47","author":"Ikeda","year":"1987","journal-title":"Cancer Res"},{"key":"key20180107214348_b17-or-29-02-0676","first-page":"3593","article-title":"Down-regulation of P-glycoprotein is associated with resistance to cisplatin and VP-16 in human lung cancer cell lines","volume":"30","author":"Wang","year":"2010","journal-title":"Anticancer Res"},{"key":"key20180107214348_b18-or-29-02-0676","doi-asserted-by":"crossref","first-page":"31542","DOI":"10.1074\/jbc.M703964200","article-title":"(R)- and (S)-verapamil differentially modulate the multidrug-resistant protein MRP1","volume":"282","author":"Perrotton","year":"2007","journal-title":"J Biol Chem"},{"key":"key20180107214348_b19-or-29-02-0676","doi-asserted-by":"crossref","first-page":"30962","DOI":"10.1074\/jbc.272.49.30962","article-title":"ATPase activity of purified multidrug resistance-associated protein","volume":"272","author":"Chang","year":"1997","journal-title":"J Biol Chem"},{"key":"key20180107214348_b20-or-29-02-0676","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/mt.2011.230","article-title":"Verapamil results in increased blood levels of oncolytic adenovirus in treatment of patients with advanced cancer","volume":"20","author":"Koski","year":"2012","journal-title":"Mol Ther"},{"key":"key20180107214348_b21-or-29-02-0676","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12013-011-9198-0","article-title":"Clinical efficacy of chemotherapy combined with verapamil in metastatic colorectal patients","volume":"61","author":"Liu","year":"2011","journal-title":"Cell Biochem Biophys"},{"key":"key20180107214348_b22-or-29-02-0676","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/0008-5472.CAN-2820-2","article-title":"Emodin enhances arsenic trioxide-induced apoptosis via generation of reactive oxygen species and inhibition of survival signaling","volume":"64","author":"Yi","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107214348_b23-or-29-02-0676","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.freeradbiomed.2006.02.016","article-title":"Alteration of subcellular redox equilibrium and the consequent oxidative modification of nuclear factor kappaB are critical for anticancer cytotoxicity by emodin, a reactive oxygen species-producing agent","volume":"40","author":"Jing","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"key20180107214348_b24-or-29-02-0676","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1038\/sj.onc.1210289","article-title":"Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines","volume":"26","author":"Igarashi","year":"2007","journal-title":"Oncogene"},{"key":"key20180107214348_b25-or-29-02-0676","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/1471-2407-10-344","article-title":"Tanzanian malignant lymphomas: WHO classification, presentation, ploidy, proliferation and HIV\/EBV association","volume":"10","author":"Mwakigonja","year":"2010","journal-title":"BMC Cancer"},{"key":"key20180107214348_b26-or-29-02-0676","first-page":"1291","article-title":"Oral Kaposi\u2019s sarcoma in Tanzania: presentation, immunopathology and human herpesvirus-8 association","volume":"17","author":"Mwakigonja","year":"2007","journal-title":"Oncol Rep"},{"key":"key20180107214348_b27-or-29-02-0676","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2010.03.008","article-title":"Reactive oxygen species-mediated endoplasmic reticulum stress and mitochondrial dysfunction contribute to cirsimaritin-induced apoptosis in human gallbladder carcinoma GBC-SD cells","volume":"295","author":"Quan","year":"2010","journal-title":"Cancer Lett"},{"key":"key20180107214348_b28-or-29-02-0676","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.lfs.2010.02.012","article-title":"ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy","volume":"86","author":"Ding","year":"2010","journal-title":"Life Sci"},{"key":"key20180107214348_b29-or-29-02-0676","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/07357900802173562","article-title":"Multidrug resistance mediated by MRP1 gene overexpression in breast cancer patients","volume":"27","author":"Abaan","year":"2009","journal-title":"Cancer Invest"},{"key":"key20180107214348_b30-or-29-02-0676","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00280-010-1385-y","article-title":"Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells","volume":"67","author":"Donmez","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107214348_b31-or-29-02-0676","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"key20180107214348_b32-or-29-02-0676","first-page":"85","article-title":"The individualization of cancer therapy: the unexpected role of p53","volume":"117","author":"Hait","year":"2006","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"key20180107214348_b33-or-29-02-0676","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.leu.2404523","article-title":"Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase\/Akt signal transduction network in human acute myelogenous leukemia blasts","volume":"21","author":"Tazzari","year":"2007","journal-title":"Leukemia"},{"key":"key20180107214348_b34-or-29-02-0676","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1158\/1078-0432.CCR-04-1764","article-title":"Role of intracellular glutathione in cell sensitivity to the apoptosis induced by tumor necrosis factor {alpha}-related apoptosis-inducing ligand\/anticancer drug combinations","volume":"11","author":"Meurette","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20180107214348_b35-or-29-02-0676","first-page":"5902","article-title":"Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells","volume":"54","author":"Cole","year":"1994","journal-title":"Cancer Res"},{"key":"key20180107214348_b36-or-29-02-0676","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0006-2952(01)00681-5","article-title":"Verapamil-stimulated glutathione transport by the multidrug resistance-associated protein (MRP1) in leukaemia cells","volume":"62","author":"Cullen","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"key20180107214348_b37-or-29-02-0676","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1016\/j.bmc.2010.07.031","article-title":"Iodination of verapamil for a stronger induction of death, through GSH efflux, of cancer cells overexpressing MRP1","volume":"18","author":"Barattin","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"key20180107214348_b38-or-29-02-0676","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1158\/0008-5472.CAN-04-0143","article-title":"Verapamil and its derivative trigger apoptosis through glutathione extrusion by multidrug resistance protein MRP1","volume":"64","author":"Trompier","year":"2004","journal-title":"Cancer Res"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2012.2156\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T01:05:02Z","timestamp":1562375102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2012.2156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,28]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,11,28]]},"published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.3892\/or.2012.2156"],"URL":"https:\/\/doi.org\/10.3892\/or.2012.2156","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,28]]}}}